GKOS Stock Analysis: Buy, Sell, or Hold?
GKOS - Glaukos Corporation
$166.72
-1.80 (-1.07%)
▼
5d:
+8.56%
30d:
+21.19%
90d:
+16.04%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jul 29, 2026
0d
Get Alerted When GKOS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: GKOS trades at premium valuation expecting 5.5% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: GKOS trades at premium valuation expecting 5.5% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$17.32
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$10.75
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: GKOS is currently trading at $166.72, which is considered extended relative to its 30-day fair value range of $141.58 to $157.95. From a valuation perspective, the stock is trading at a premium (Forward PE: 337.3) compared to its historical average (287.5). At these levels, the market is pricing in 5.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, GKOS is in a strong uptrend. Immediate support is located at $145.78, while resistance sits at $184.00.
Market Sentiment: GKOS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $191.54 (+14.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, GKOS is in a strong uptrend. Immediate support is located at $145.78, while resistance sits at $184.00.
Market Sentiment: GKOS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $191.54 (+14.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$141.58 -
$157.95
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
54.8%
Protect Your Profits
GKOS is technically overbought (RSI 71). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+5.6% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($191.54)
- NEUTRAL: PE elevated vs history but 5.5% growth expectation is conservative given 1896% recent growth
Trading Range Analysis
30-Day Trading Range
$141.58 -
$157.95
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$145.78
Resistance Level
$184.00
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
337.29
Wall Street Target
$191.54
(+14.9%)
Revenue Growth (YoY)
49.5%
Earnings Growth (YoY)
1896.3%
Profit Margin
-30.7%
Valuation Premium vs History
+5.5% premium
PE vs Historical
337.3 vs 287.5
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.5%
(market-implied from PE analysis)
1-Year Target
$175.89
(+6%)
2-Year Target
$185.56
(+11%)
3-Year Target
$195.77
(+17%)
3-Yr Target (if PE normalizes)
(PE: 337→288)
PE COMPRESSION
$166.87
(+0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: August 02, 2026 11:09 AM ET
Data refreshes hourly during market hours. Next update: 12:09 PM
Data refreshes hourly during market hours. Next update: 12:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GKOS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Alex R Thurman
SELL
2511 shares
2026-03-25
Alex R Thurman
SELL
1521 shares
2026-03-24
Alex R Thurman
SELL
625 shares
2026-03-17
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 55 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 51 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 52 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 57 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$236 | 51 HOLD |
Advanced GKOS Option Strategies
Professional options setups generated by AI based on today's GKOS price and gamma walls.
